Both TLR2 and TLR4 are expressed on the surface of innate myeloid cells, such as macrophages and dendritic cells, but also endothelial and epithelial cells, and are key initiators of the innate anti-tumour immune response [39]. The gene discussed is TLR2; the disease is neoplasm.